Navigation Links
HealthLink Europe's U.S. Operation Supports First FDA IDE Trial
Date:11/11/2013

RALEIGH, N.C. and 'S-HERTOGENBOSCH, Netherlands, Nov. 11, 2013 /PRNewswire/ -- HealthLink Europe, an ISO 13485:2012 certified company specializing in providing front and back office support, VAT deferment, fulfillment and logistics services to medical device companies since 1994, is now supporting a European-based client's FDA IDE Trial in the United States for a Class III device in the interventional cardiology space.

HealthLink Europe has had a Business Development and Client Relations office based in Raleigh, North Carolina since 2004, but they have now expanded their North American capabilities to include logistical support. HealthLink's expansion of operational services to the U.S. offers its current clients the advantage of working with the same platform for their sites in the U.S. as they do for their European operations.

HealthLink plans to grow its North American warehousing and logistics services with the expansion of its U.S. team based in Raleigh, North Carolina. Sebastiaan "Bas" de Kok, Operations Manager at HealthLink Europe, will join the U.S.A. team this year, bringing with him the knowledge and experience necessary to further develop HealthLink's North American endeavor.

"It is our plan to have a North American operation that offers similar services to our current European facility in the Netherlands," explains Rick Hughes, president of HealthLink Europe. "We're very excited about our expansion and we're looking forward to supporting our clients as they expand into other markets."

ABOUT HEALTHLINK EUROPE:
HealthLink Europe is 100% medical, ISO 13485 certified, specializing in class II and III devices and their associated regulatory requirements.

Acting as an extension of its customers' business, HealthLink provides Customer Care Services, Financial Services, Warehousing and Logistics, Fulfillment and Value Added Services, IT Support, Authorized Representative services, and more.

For more information, visit www.healthlinkeurope.com, or call Toll Free:(800) 781-8926.

For media inquiries, please contact:
Savanna Bohlman Fann
Communications Manager, HealthLink Europe
(800) 781-8926


'/>"/>
SOURCE HealthLink Europe
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
2. PharmAthene Reports Third Quarter 2013 Financial And Operational Results
3. Intersurgical, ERDRICH Umformtechnik und Bridgestone gehen Kooperation mit dem Changzhou National Hi-Tech District ein
4. Celtaxsys Restructures, Enhances Operational Focus
5. Neue Studie kommt zu dem Schluss, dass manche Patienten mit Refluxkrankheit von Stretta eher profitieren als von chronischer Behandlung mit Protonenpumpenhemmern oder Antireflux-Operation
6. GenVec Board Restructures Operations and Withdraws Plan of Dissolution
7. X-Change Corp. Delighted with DOJs Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees Green Light for Companys Patient-Driven Medical Cannabis Operations Under State Laws
8. PA Governor Corbett: Americure Rx Establishes Operations in Lehigh Valley; Creates 51 Jobs
9. PendoTECH Launches New In-line Single Use Conductivity Sensors for Critical Bioprocess Operations
10. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
11. Ambit Biosciences to Announce Second Quarter 2013 Operational Results and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... 2017  West Pharmaceutical Services, Inc. (NYSE: ... second-quarter 2017 and updated financial guidance for the full-year ... Highlights Reported net sales of $397.6 ... quarter. Net sales at constant currency (organic) grew by ... $0.51, compared to $0.60 in the prior-year quarter. Second-quarter ...
(Date:7/26/2017)... Sancilio Pharmaceuticals Company, Inc. (SPCI) today announced ... Altemia TM , an oral therapy for pediatric patients ... (SCD). The SCOT Trial, is a double-blind, placebo-controlled, dose-finding, ... Altemia TM in pediatric patients aged 5-17 years ... "The completion of ...
(Date:7/25/2017)... Fla. , July 25, 2017  Debbie,s Dream Foundation: Curing Stomach Cancer ... on Monday, September 25, 2017 at the Bonaventure Resort & Spa in ... ... DDF Founder and President Debbie Zelman, and Luncheon Committee Co-chair Sabrina Kurzman. ... Aura ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Any Lab Test ... The company ranked #4429 on the newly released, 36th annual Inc. 5000 , ... unique look at the most successful companies within the American economy’s most dynamic segment ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... of their recently launched community enrichment program. Partnering once again with Boys & ... Superstar competition to help find the area’s very own American Idol. With all ...
(Date:8/16/2017)... PA (PRWEB) , ... August 16, 2017 , ... A ... it has successfully opened clubfoot clinics in all 29 Indian states—bringing the country one ... clinic in Kangra, Himachal Pradesh, the nonprofit organization is on track to enroll 10,000 ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... company based in Vero Beach, announced today that two of their associates were ... that represents professionally managed senior living communities in Florida. The awards were announced ...
(Date:8/16/2017)... ... August 16, 2017 , ... The ... men and women to train as hospice volunteers. Volunteers provide much needed joy, ... over 30 years, the agency has trained volunteers to be vital members of ...
Breaking Medicine News(10 mins):